Sign in
Taking people in United StatesNo phase

Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens

Key facts

Who runs it
Carl Zeiss Meditec AG
Where
Lynchburg and Sugar Land, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
Jul 2025
Planned end
Sept 2026
Type of study
Observational
Treatments tested
  • CT LUCIA 621P Intraocular Lens Implantation
Record updated
24 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Be at least 18 years of age or older
  • Previous cornea LVC surgery performed at least 1 year before the implantation of the CT LUCIA 621P IOL, such as Laser-Assisted Intrastromal Keratomileusis (LASIK), Laser-Assisted Subepithelial Keratectomy (LASEK), Photorefractive Keratectomy (PRK) or Small Incision Lenticule Extraction (SMILE) for mild to moderate myopia, with or without astigmatism (up to, but not including, -6.0 D sphere in any meridian for myopic ablations
  • Presenting for planned bilateral cataract extraction with in-the-bag posterior chamber IOL implantation, via phacoemulsification with or without femtosecond laser assisted cataract surgery (FLACS). Astigmatism management techniques, such as Astigmatic Keratotomy (AK), may be utilized during cataract surgery to target a predicted postoperative cylinder less than 0.75 D
  • Clear intraocular media other than cataract (i.e., no hyphema, vitreous hemorrhage)
  • No visual acuity limiting corneal or retinal pathologies
  • Able to and having provided written informed consent and a signed Health Insurance Portability and Accountability Act (HIPAA) form
  • Availability, willingness, ability, and sufficient cognitive awareness to comply with study examination procedures and the schedule for study visits and evaluations

Who cannot take part

  • Subjects with surgical complications in whom a CT LUCIA 621P IOL cannot be implanted in either eye
  • Eyes with irregular corneal astigmatism, epithelial basement membrane dystrophy, chronic dry eye requiring continual treatment, underwent more than one LVC procedure in one or both eyes, or complications from the previous LVC which required additional surgical intervention
  • Subjects with planned ocular surgery during the study (except Nd:YAG capsulotomy is permitted)
  • Previous radial keratotomy (RK)
  • Previous corneal keratoplasty (e.g., corneal transplant, Descemet's stripping automated endothelial keratoplasty (DSAEK), lamellar keratoplasty)
  • Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)
  • Concurrent participation in another device investigation
  • Subjects with diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that would confound visual acuity measurement
  • History of acute or chronic disease, pathology, illness, or ocular trauma that would, in the opinion of the investigator, confound results
  • Current diagnosis of macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, amblyopia, or other chronic ocular conditions that would confound the study results
  • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils, or pupils that do not dilate under mesopic/scotopic conditions)
  • Capsular or zonular abnormalities or other conditions that may affect the postoperative centration or tilt of the lens (e.g., pseudoexfoliation syndrome)
  • Implantation of an IOL other than the CT LUCIA 621P in one or both eyes
  • Eyes with preoperative anterior corneal astigmatism of ΔTK ≥1.00 D as measured by the IOLMaster 700 or with greater than 0.75 D predicted post-operative astigmatism at the spectacle plane
  • Visual field loss which has an impact on visual acuity
  • A current diagnosis of moderate or severe glaucoma
  • Patients with strabismus, forme fruste keratoconus, keratoconus or other corneal pathologies that would confound visual acuity measurement
  • Usage of contact lenses during study participation

Where in United States

  • Piedmont Eye CenterLynchburg, United StatesContact: Mishael BenjaminTaking people
  • Berkeley Eye CenterSugar Land, United StatesContact: Tetiana HuffTaking people

About the trial

What the trial wants to find out

This is a prospective, Phase IV, post-approval observational study evaluating postoperative outcomes in patients with a history of myopic corneal laser vision correction (LVC) undergoing bilateral cataract surgery with implantation of the CT LUCIA 621P intraocular lens (IOL). Up to 30 subjects (60 eyes) will be enrolled across up to three U.S. investigational sites. The study will assess visual and refractive outcomes, including biometry, manifest refraction, and patient-reported visual function over a 3-month follow-up period.

The group in the trial

  • CT LUCIA 621P IOL Implantation Group

    Subjects with prior myopic corneal laser vision correction undergoing bilateral cataract surgery implanted with the CT LUCIA 621P intraocular lens. All subjects will be followed prospectively to assess postoperative visual and refractive outcomes.

    Treatment: CT LUCIA 621P Intraocular Lens Implantation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
EPIC: Evaluation of the Postoperative Cataract Surgery Outcomes in Patients With Prior Corneal Laser Vision Correction Implanted With the CT LUCIA Intraocular Lens Protocol GPAS-SAS-023-4
Record updated
24 July 2025